Metabolon Raises $15M in Preferred Stock Offering | GenomeWeb

NEW YORK (GenomeWeb News) — Metabolon announced Friday that it has raised $15 million through a private placement of preferred stock.

Investors in the Series E round included Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght, and Fulcrum Financial Partners, as well as Japanese firm Sumitomo. The round was led by Camden Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.